AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35

Authors: GURMAN G KOC H AKAN H ILHAN O OZCAN M ARSLAN O SUNGUROGLU A KONUK N BEKSAC M UYSAL A
Citation: G. Gurman et al., DONOR MONONUCLEAR-CELLS INFUSION AND ALFA INTERFERON ADMINISTRATION IN RELAPSED CHRONIC MYELOID-LEUKEMIA PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 3800-3800

Authors: USTUN C KOC H KARAYALCIN S AKYOL G GURMAN G ILHAN O AKAN H OZCAN M ARSLAN O KONUK N UYSAL A BEKSAC M
Citation: C. Ustun et al., HEPATIC COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 3815-3815

Authors: ILHAN O OZCAN M BEKSAC M KOC H AKAN H KUTLAY S DALVA K GURMAN G ARSLAN O ARAT M DILEK I KONUK N UYSAL A
Citation: O. Ilhan et al., THE PROGNOSTIC RELEVANCE OF HLA PHENOTYPE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION IN TURKISH PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 88(10), 1996, pp. 3825-3825

Authors: BEKSAC M ARAT M OZCAN M ARSLAN O KOC H AKAN H ILHAN O GURMAN G KONUK N UYSAL A
Citation: M. Beksac et al., COMPARISON OF PERIPHERAL-BLOOD, LYMPH-NODE AND BONE-MARROW LYMPHOCYTESURFACE-ANTIGENS, ADHESION MOLECULES IN B-CLL AND LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 88(10), 1996, pp. 958-958

Authors: GURMAN G KAHVECI G AKAN H ILHAN O KOC H BEKSAC M KONUK N UYSAL A
Citation: G. Gurman et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS A 2ND TRANSPLANT FOR SEVERE APLASTIC-ANEMIA, Bone marrow transplantation, 15(3), 1995, pp. 485-486

Authors: ILHAN O BEKSAC M KOC H AKAN H KESKIN A ARSLAN O GURMAN G OCAN M KONUK N UYSAL A
Citation: O. Ilhan et al., HLA-DR FREQUENCY IN TURKISH APLASTIC-ANEMIA PATIENTS AND THE IMPACT OF HLA-DR2 POSITIVITY IN RESPONSE RATE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY, Blood, 86(5), 1995, pp. 2055-2056

Authors: ILHAN O BEKSAC M KOC H AKAN H KESKIN A ARSLAN O GURMAN G OCAN M KONUK N UYSAL A
Citation: O. Ilhan et al., HLA-DR FREQUENCY IN TURKISH APLASTIC-ANEMIA PATIENTS AND THE IMPACT OF HLA-DR2 POSITIVITY IN RESPONSE RATE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY, Blood, 86(5), 1995, pp. 2055-2055

Authors: KOC H AKAN H ILHAN O GURMAN G OZCAN M ARSLAN O BEKSAC M KONUK N UYSAL A
Citation: H. Koc et al., RELATIONSHIP BETWEEN SERUM CYTOKINE LEVELS AND APLASIA PERIOD FOLLOWING HIGH-DOSE CHEMOTHERAPY SUPPORTED BY GRANULOCYTE-COLONY-STIMULATING FACTOR AS A SALVAGE CHEMOTHERAPY WITHOUT STEM-CELL RESCUE IN MALIGNANT-LYMPHOMAS, Blood, 86(10), 1995, pp. 2779-2779

Authors: ILHAN O ARSLAN O KOC H BEKSAC M AKAN H GURMAN G OZCAN M KONUK N UYSAL A
Citation: O. Ilhan et al., HIGH-DOSE EPIRUBICIN CONTAINING CEOP REGIMEN IN INTERMEDIATE OR HIGH-GRADE NONHODGKINS LYMPHOMA, Blood, 86(10), 1995, pp. 3245-3245

Authors: ARSLAN O AKAN H BEKSAC M ILHAN O KOC H KONUK N
Citation: O. Arslan et al., TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) POSITIVITY IN ACUTE NONLYMPHOBLASTIC LEUKEMIA, Leukemia, 8(6), 1994, pp. 1067-1067
Risultati: 1-25 | 26-35 |